Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Keystone

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Current Opinion in Rheumatology|April 15, 2009
Recent concepts in the inhibition of radiographic progression with biologicsEdward Keystone
Arthritis Research & Therapy|June 18, 2005
B cell targeted therapiesEdward Keystone
The Journal of Rheumatology. Supplement|November 7, 2007
Optimizing treatment with biologicsReuven Mader, Edward Keystone
Rheumatic Diseases Clinics of North America|June 3, 2004
Adalimumab therapy in rheumatoid arthritisEdward Keystone, Boulos Haraoui
Current Opinion in Rheumatology|December 14, 2005
Musculoskeletal manifestations and autoimmune diseases related to new biologic agentsBoulos Haraoui, Edward Keystone
Rheumatology and Therapy|October 18, 2016
Rituximab for Rheumatoid ArthritisMarc D Cohen, Edward Keystone
Current Rheumatology Reports|August 20, 2013
Cell-signaling therapy in rheumatoid arthritisEdward Keystone, Marc D Cohen
Expert Opinion on Biological Therapy|July 11, 2015
Subcutaneous abatacept in rheumatoid arthritis: current updateEdward Keystone, Abdulaziz Alkhalaf, Mosaab Makkawy
Arthritis and Rheumatism|October 4, 2005
Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?Josef S Smolen, Daniel Aletaha, Edward Keystone
Rheumatology (Oxford, England)|February 26, 2010
Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?Arthur Kavanaugh, Edward Keystone, JingYuan Feng, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Current Opinion in Rheumatology|April 15, 2009
Recent concepts in the inhibition of radiographic progression with biologicsEdward Keystone
Arthritis Research & Therapy|June 18, 2005
B cell targeted therapiesEdward Keystone
The Journal of Rheumatology. Supplement|November 7, 2007
Optimizing treatment with biologicsReuven Mader, Edward Keystone
Rheumatic Diseases Clinics of North America|June 3, 2004
Adalimumab therapy in rheumatoid arthritisEdward Keystone, Boulos Haraoui
Current Opinion in Rheumatology|December 14, 2005
Musculoskeletal manifestations and autoimmune diseases related to new biologic agentsBoulos Haraoui, Edward Keystone
Rheumatology and Therapy|October 18, 2016
Rituximab for Rheumatoid ArthritisMarc D Cohen, Edward Keystone
Current Rheumatology Reports|August 20, 2013
Cell-signaling therapy in rheumatoid arthritisEdward Keystone, Marc D Cohen
Expert Opinion on Biological Therapy|July 11, 2015
Subcutaneous abatacept in rheumatoid arthritis: current updateEdward Keystone, Abdulaziz Alkhalaf, Mosaab Makkawy
Arthritis and Rheumatism|October 4, 2005
Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?Josef S Smolen, Daniel Aletaha, Edward Keystone
Rheumatology (Oxford, England)|February 26, 2010
Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?Arthur Kavanaugh, Edward Keystone, JingYuan Feng, et al.
Pageof 9